David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.45% |
| 2 | Consumer Discretionary | 10.49% |
| 3 | Communication Services | 9.04% |
| 4 | Healthcare | 8.89% |
| 5 | Financials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FFWM
3076
DELISTED
First Foundation Inc
FFWM
| $872K | ﹤0.01% |
+37,172
| New | +$831K |
|
|
DS
3077
DELISTED
Drive Shack Inc.
DS
| $871K | ﹤0.01% |
271,261
+233,008
| +609% | +$632K |
|
3078
CALL
Gogo Inc
GOGO
$369M
| $869K | ﹤0.01% |
90,000
| – | – |
|
|
WIRE
3079
DELISTED
Encore Wire Corp
WIRE
| $865K | ﹤0.01% |
12,878
-11,897
| -48% | -$770K |
|
3080
CALL
Live Oak Bancshares
LOB
$1.85B
| $863K | ﹤0.01% |
+12,600
| New | +$661K |
|
3081
Teva Pharmaceuticals
TEVA
$44.4B
| $863K | ﹤0.01% |
74,793
-608,800
| -89% | -$6.98M |
|
3082
Cactus
WHD
$5.39B
| $863K | ﹤0.01% |
28,176
-133,553
| -83% | -$4.05M |
|
3083
Clearway Energy Class C
CWEN
$6.67B
| $861K | ﹤0.01% |
+30,608
| New | +$940K |
|
3084
Arcos Dorados Holdings
ARCO
$1.71B
| $858K | ﹤0.01% |
170,913
+138,326
| +424% | +$709K |
|
3085
Clarus
CLAR
$145M
| $855K | ﹤0.01% |
50,151
+22,126
| +79% | +$376K |
|
3086
Forte Biosciences
FBRX
$1.63B
| $855K | ﹤0.01% |
+998
| New | +$817K |
|
3087
Neurocrine Biosciences
NBIX
$15.6B
| $849K | ﹤0.01% |
8,732
-1,148
| -12% | -$120K |
|
3088
CALL
Cirrus Logic
CRUS
$5.58B
| $848K | ﹤0.01% |
10,000
-45,500
| -82% | -$3.94M |
|
|
CKH
3089
DELISTED
Seacor Holdings Inc.
CKH
| $848K | ﹤0.01% |
20,815
-570
| -3% | -$23.8K |
|
3090
PUT
TechTarget
TTGT
$281M
| $847K | ﹤0.01% |
+12,200
| New | +$949K |
|
|
SWBK.U
3091
DELISTED
Switchback II Corporation Units, each consisting of one Class A ordinary share and one fifth of one
SWBK.U
| $847K | ﹤0.01% |
+83,174
| New | +$960K |
|
3092
Lennar Class B
LEN.B
$20.7B
| $844K | ﹤0.01% |
10,779
-39
| -0.4% | -$2.6K |
|
3093
Weis Markets
WMK
$1.75B
| $842K | ﹤0.01% |
14,895
-3,843
| -21% | -$206K |
|
3094
ATN International
ATNI
$473M
| $840K | ﹤0.01% |
17,104
+3,135
| +22% | +$149K |
|
|
SCOA
3095
DELISTED
ScION Tech Growth I Class A Ordinary Shares
SCOA
| $839K | ﹤0.01% |
+85,677
| New | +$866K |
|
3096
Booz Allen Hamilton
BAH
$8.88B
| $837K | ﹤0.01% |
10,390
-62,112
| -86% | -$5.21M |
|
3097
Plexus
PLXS
$6.42B
| $835K | ﹤0.01% |
9,091
-5,128
| -36% | -$435K |
|
3098
Mizuho Financial
MFG
$126B
| $834K | ﹤0.01% |
286,726
-41,478
| -13% | -$121K |
|
|
ATAQ.U
3099
DELISTED
Altimar Acquisition Corp III Units
ATAQ.U
| $833K | ﹤0.01% |
+83,333
| New | +$834K |
|
|
AGC
3100
DELISTED
Altimeter Growth Corp
AGC
| $831K | ﹤0.01% |
+71,031
| New | +$954K |
|
Similar funds
David Shaw's Q1 2021 Portfolio in Review
As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
David Shaw withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, David Shaw opened a new position in Baidu worth $627M.
- David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
- David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- David Shaw opened 825 new positions and closed 730 in Q1 2021.
- David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.